glp 1 neuroprotection Visual representation of the beneficial roles of GLP-1RA in Model diagram of potential mechanisms

GLP5 is an early-stage compound whose exact structure stays confidential for now, so the sequence shown differs from publicly referenced versions and independent lab testing is not yet possible

Australia banned compounded tirzepatide entirely after multiple reports of adverse reactions

Then in May 2022, the FDA approved tirzepatide (Mounjaro) for type 2 diabetes the first GIP/GLP-1 dual agonist, hitting two incretin receptors at once and producing larger A1c and weight effects in the SURPASS program than any prior single-mechanism GLP-1

GLP-1 receptor agonists for prevention of cardiorenal outcomes in type 2 diabetes: An updated meta-analysis including the REWIND and PIONEER 6 trials